| scholarly article | Q13442814 |
| P50 | author | Klaus P. Ebmeier | Q42370256 |
| Michael F Glabus | Q113645500 | ||
| Guy M. Goodwin | Q5622285 | ||
| P2093 | author name string | Shah PJ | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 527-532 | |
| P577 | publication date | 1998-06-01 | |
| P1433 | published in | British Journal of Psychiatry | Q4035428 |
| P1476 | title | Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study | |
| P478 | volume | 172 |
| Q73154073 | 3D MRI studies of neuroanatomic changes in unipolar major depression: the role of stress and medical comorbidity |
| Q51899438 | A longitudinal analysis of neurocognitive function in unipolar depression. |
| Q48180146 | A voxel-based morphometric MRI study in female patients with borderline personality disorder |
| Q48420535 | A voxel-based morphometry study of temporal lobe gray matter reductions in Alzheimer's disease |
| Q28140495 | Adult brain neurogenesis and psychiatry: a novel theory of depression |
| Q35204087 | Affective disorders, antidepressant drugs and brain metabolism |
| Q45734792 | Ageing abolishes the effects of fluoxetine on neurogenesis |
| Q31968581 | Aging affects transcranial magnetic modulation of hippocampal evoked potentials |
| Q47802190 | Amygdala and regional volumes in treatment-resistant versus nontreatment-resistant depression patients |
| Q52017630 | Amygdala-hippocampal volume and verbal memory in first-degree relatives of schizophrenic patients. |
| Q30719485 | Anatomical MRI findings in mood and anxiety disorders. |
| Q34532241 | Annual research review: progress in using brain morphometry as a clinical tool for diagnosing psychiatric disorders |
| Q37248756 | Anomalous gray matter structural networks in major depressive disorder. |
| Q34622363 | Antidepressant mechanisms: functional and molecular correlates of excitatory amino acid neurotransmission |
| Q30655315 | Are child-, adolescent-, and adult-onset depression one and the same disorder? |
| Q35620838 | Association of depression with medical illness: does cortisol play a role? |
| Q27015612 | Biomarkers of epileptogenesis: psychiatric comorbidities (?) |
| Q33442474 | Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide |
| Q26786239 | Brain Structural Effects of Antidepressant Treatment in Major Depression |
| Q36003816 | Brain plasticity and antidepressant treatments: new cells, new connections |
| Q44066592 | Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies |
| Q35236779 | Cellular abnormalities in depression: evidence from postmortem brain tissue |
| Q34090433 | Cellular changes in the postmortem hippocampus in major depression |
| Q44612591 | Cerebral benzodiazepine receptors in depressed patients measured with [123I]iomazenil SPECT. |
| Q43713433 | Cerebral metabolism in major depression and obsessive-compulsive disorder occurring separately and concurrently |
| Q48243726 | Cerebral volume measurements and subcortical white matter lesions and short-term treatment response in late life depression |
| Q34325687 | Cerebrospinal fluid space alterations in melancholic depression. |
| Q35591603 | Childhood trauma associated with smaller hippocampal volume in women with major depression. |
| Q33754464 | Clinical translation of neuroimaging research in mood disorders. |
| Q35737297 | Cognitive and neurological impairment in mood disorders |
| Q31069918 | Cognitive impairment and fMRI in major depression. |
| Q30249189 | Common Mechanisms Underlying Epileptogenesis and the Comorbidities of Epilepsy |
| Q36826795 | Comorbidity implications in brain disease: neuronal substrates of symptom profiles |
| Q37415050 | Could stress cause psychosis in individuals vulnerable to schizophrenia? |
| Q34331120 | Course of illness, hippocampal function, and hippocampal volume in major depression |
| Q51968849 | Current evidence for subjective cognitive impairment (SCI) as the pre-mild cognitive impairment (MCI) stage of subsequently manifest Alzheimer's disease. |
| Q35236749 | Current perspectives in the management of treatment-resistant depression. |
| Q48173300 | Decreased quinolinic acid in the hippocampus of depressive patients: evidence for local anti-inflammatory and neuroprotective responses? |
| Q34153354 | Deep brain stimulation for treatment-resistant depression |
| Q35020089 | Depression and chronic diabetic foot disability. A case report of suicide |
| Q48750153 | Depression and the risk of neurological disorders |
| Q36479064 | Depression uncouples brain hate circuit. |
| Q33759114 | Depressive illness |
| Q44780795 | Differential autoreceptor control of extracellular 5-HT in guinea pig and rat: species and regional differences |
| Q35004034 | Diminished serum repetin levels in patients with schizophrenia and bipolar disorder |
| Q35162912 | ECT of major depressed patients in relation to biological and clinical variables: a brief overview |
| Q46965132 | Early preweaning methamphetamine and postweaning rearing conditions interfere with the development of peripheral stress parameters and neural growth factors in gerbils |
| Q36857790 | Effect of hippocampal and amygdala volumes on clinical outcomes in major depression: a 3-year prospective magnetic resonance imaging study |
| Q73154068 | Effects of early adverse experiences on brain structure and function: clinical implications |
| Q35111592 | Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for Difficult-to-Treat depression |
| Q35236446 | Enhancing synaptic plasticity and cellular resilience to develop novel, improved treatments for mood disorders. |
| Q48619140 | Enlargement of the amygdala in patients with a first episode of major depression |
| Q38897362 | Experimental Medicine in Psychiatry New Approaches in Schizophrenia, Depression and Cognition |
| Q48843482 | Face emotion perception and executive functioning deficits in depression |
| Q30577346 | Feasibility of studying brain morphology in major depressive disorder with structural magnetic resonance imaging and clinical data from the electronic medical record: a pilot study |
| Q47731679 | Fluoxetine reverses behavior changes in socially isolated rats: role of the hippocampal GSH-dependent defense system and proinflammatory cytokines. |
| Q36003798 | Gene-environment interplay in neurogenesis and neurodegeneration |
| Q34641123 | Geriatric depression and cognitive impairment |
| Q43878259 | Glucose metabolism in the amygdala in depression: relationship to diagnostic subtype and plasma cortisol levels |
| Q36026816 | Gray matter differences between healthy and depressed adolescents: a voxel-based morphometry study |
| Q51965098 | Hippocampal atrophy is the critical brain change in patients with hypoxic amnesia. |
| Q47870671 | Hippocampal function in posttraumatic stress disorder |
| Q35869161 | Hippocampal neurogenesis, depressive disorders, and antidepressant therapy |
| Q34486424 | Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment |
| Q24795618 | Hippocampal volume in early onset depression |
| Q33324413 | Hippocampus shape analysis and late-life depression |
| Q48458465 | Hippocampus, glucocorticoids and neurocognitive functions in patients with first-episode major depressive disorders. |
| Q34625080 | History of depression as a risk factor for dementia: an updated review. |
| Q45115322 | IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity |
| Q33924327 | Imaging serotonergic neurotransmission in depression: hippocampal pathophysiology may mirror global brain alterations |
| Q48082633 | Impact of monoamine-related gene polymorphisms on hippocampal volume in treatment-resistant depression |
| Q33404025 | Improving the prediction of treatment response in depression: integration of clinical, cognitive, psychophysiological, neuroimaging, and genetic measures. |
| Q73914669 | Increased neurogenesis in a model of electroconvulsive therapy |
| Q30961081 | Is major depression a neurologic disorder with psychiatric symptoms? |
| Q48449783 | Lack of self-control as assessed by a personality inventory is related to reduced volume of supplementary motor area |
| Q36779534 | Life-long hippocampal neurogenesis: environmental, pharmacological and neurochemical modulations |
| Q44207595 | Longitudinal MR study of brain structure and hippocampus volume in major depressive disorder |
| Q30955567 | MR-based in vivo hippocampal volumetrics: 1. Review of methodologies currently employed. |
| Q30957247 | MR-based in vivo hippocampal volumetrics: 2. Findings in neuropsychiatric disorders. |
| Q30724972 | Magnetic resonance imaging predictors of treatment response in late-life depression |
| Q44746502 | Medical comorbidity in recurrent versus first-episode depressive patients |
| Q48158671 | Microglia activation regulates GluR1 phosphorylation in chronic unpredictable stress-induced cognitive dysfunction |
| Q31059298 | Mood disorders - review of structural MRI studies |
| Q21203922 | Mourning and melancholia revisited: correspondences between principles of Freudian metapsychology and empirical findings in neuropsychiatry |
| Q45960669 | Multi-centre diagnostic classification of individual structural neuroimaging scans from patients with major depressive disorder. |
| Q95270387 | Neurobehavioral Mechanisms of Resilience Against Emotional Distress: An Integrative Brain-Personality-Symptom Approach Using Structural Equation Modeling |
| Q30815738 | Neuroimaging studies of mood disorder effects on the brain |
| Q34111006 | Neuroplasticity and cellular resilience in mood disorders |
| Q35236788 | Neuroplasticity in mood disorders |
| Q35610797 | Neuropsychophysiological correlates of depression |
| Q34084297 | Orbitofrontal volume reductions during emotion recognition in patients with major depression |
| Q31925937 | Physical activity-antidepressant treatment combination: impact on brain-derived neurotrophic factor and behavior in an animal model |
| Q30492858 | Possible structural abnormality of the brainstem in unipolar depressive illness: a transcranial ultrasound and diffusion tensor magnetic resonance imaging study |
| Q33924323 | Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells |
| Q44892036 | Prediction of illness severity in patients with major depression using structural MR brain scans |
| Q33487168 | Prognostic and diagnostic potential of the structural neuroanatomy of depression |
| Q30650490 | Quest for biomarkers of treatment-resistant depression: shifting the paradigm toward risk |
| Q36368849 | Recent developments and current controversies in depression |
| Q45004316 | Recovery of hippocampal cell proliferation and BDNF levels, both of which are reduced by repeated restraint stress, is accelerated by chronic venlafaxine |
| Q37010297 | Reduced caudate gray matter volume in women with major depressive disorder |
| Q35012657 | Reduced hippocampal volume correlates with executive dysfunctioning in major depression. |
| Q34124198 | Reduced volume of orbitofrontal cortex in major depression |
| Q35455418 | Reduction of frontal neocortical grey matter associated with affective aggression in patients with temporal lobe epilepsy: an objective voxel by voxel analysis of automatically segmented MRI. |
| Q35601193 | Regional brain metabolic correlates of alpha-methylparatyrosine-induced depressive symptoms: implications for the neural circuitry of depression |
| Q48868418 | Regional cerebral volume measurements in late-life depression: relationship to clinical correlates, neuropsychological impairment and response to treatment |
| Q48630254 | Regional changes in brain gray and white matter in patients with schizophrenia demonstrated with voxel-based analysis of MRI. |
| Q32062321 | Repeated electroconvulsive stimulation, but not antidepressant drugs, induces mossy fibre sprouting in the rat hippocampus |
| Q90672013 | Retinal correlates of psychiatric disorders |
| Q36614268 | Risk of Common Mental Disorders in Relation to Symptoms of Obstructive Sleep Apnea Syndrome among Ethiopian College Students |
| Q44930234 | Saliva cortisol and male depressive syndrome in a community study. The Sudurnesjamenn study |
| Q26866575 | Sex and stress hormone influences on the expression and activity of brain-derived neurotrophic factor |
| Q44392768 | Sleep deprivation reduces proliferation of cells in the dentate gyrus of the hippocampus in rats |
| Q48307194 | State-dependent changes in hippocampal grey matter in depression |
| Q35066496 | Stress hormone-related psychopathology: pathophysiological and treatment implications |
| Q34686632 | Stress, depression, and neuroplasticity: a convergence of mechanisms |
| Q30925826 | Structural MRI changes of the brain in depression |
| Q35694665 | Structural MRI-Based Predictions in Patients with Treatment-Refractory Depression (TRD). |
| Q80249687 | Structural changes in the brain in depression and relationship to symptom recurrence |
| Q24657356 | Structural integrity of the uncinate fasciculus in geriatric depression: Relationship with age of onset |
| Q48897507 | Subchronic treatment with aldosterone induces depression-like behaviours and gene expression changes relevant to major depressive disorder |
| Q46061375 | Targeting inflammation to influence cognitive function following spinal cord injury: a randomized clinical trial |
| Q34661462 | Temporal Lobe Atrophy and White Matter Lesions are Related to Major Depression over 5 years in the Elderly |
| Q34432560 | Temporal-lobe morphology differs between healthy adolescents and those with early-onset of depression |
| Q48559126 | The Danish PET/depression project: clinical symptoms and cerebral blood flow. A regions-of-interest analysis |
| Q34304937 | The Hypothalamic-Pituitary-Adrenal Axis in Major Depressive Disorder: A Brief Primer for Primary Care Physicians |
| Q33989695 | The N-methyl-D-aspartate receptor, synaptic plasticity, and depressive disorder. A critical review |
| Q38245307 | The common inflammatory etiology of depression and cognitive impairment: a therapeutic target |
| Q33203413 | The hippocampus and depression |
| Q37775892 | The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research? |
| Q37696373 | The hypothalamic-pituitary-adrenal axis and serotonin abnormalities: a selective overview for the implications of suicide prevention |
| Q33922615 | The madness of Nietzsche: a misdiagnosis of the millennium? |
| Q34673955 | The moderating effect of the APOE [small element of] 4 allele on the relationship between hippocampal volume and cognitive decline in older depressed patients |
| Q24561923 | The role of the hippocampus in the pathophysiology of major depression |
| Q24649017 | The subgenual anterior cingulate cortex in mood disorders |
| Q49156156 | Theory of mind deficits in chronically depressed patients |
| Q59600613 | Three-dimensional analysis of MRI |
| Q36107651 | Trajectories of major depression disorders: A systematic review of longitudinal neuroimaging findings |
| Q41366149 | Transcranial Magnetic Stimulation of Left Dorsolateral Prefrontal Cortex Induces Brain Morphological Changes in Regions Associated with a Treatment Resistant Major Depressive Episode: An Exploratory Analysis. |
| Q31048455 | Use of magnetic resonance imaging in tracking the course and treatment of schizophrenia |
| Q30699287 | Volumetric MRI studies of mood disorders: do they distinguish unipolar and bipolar disorder? |
| Q35026782 | White-matter tract integrity in late-life depression: associations with severity and cognition |
Search more.